Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: Final results of the non-interventional study NABUCCO.

Marschner, N., Potthoff, K., Salat, C., Söling, U., Hansen, R., Grebhardt, S., Harde, Nusch, A., 2016.

Oncol Res Treat 39 (suppl3)(P598), 183. doi:10.1159/000449050

Studie: NABUCCO; Indikation: Mammakarzinom; Jahr: 2016; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com